Fundraising FoxMVM Life Science Partners — Full Portfolio
28 tracked investments · listed companies and verified rows first
BioProtect develops a balloon spacer device for brachytherapy procedures, used to create spacing during cancer radiation treatment.
BiotechHealthtechMedical Devices
Itay Barnea(Chief Executive Officer)inDerek Webster(Chief Commercial Officer)inLee Adler(Chief Operating Officer)inShahar Shaked(Chief Financial Officer)inDafna Carmi-Yinon(Chief Product and Clinical Officer)in
Co-investorsAlmeda VenturesTriventuresOlympus Innovation VenturesPeregrine VenturesXenia Venture Capital
AccuVein manufactures vein visualization systems for medical professionals to locate veins during procedures.
HardwareHealthtechMedical DevicesCold Spring Harbor, US
Ron Goldman(Executive Officer, Director)inChris Hutchison(President & CEO)in
BoardJames Lackie(Director)Eric Bednarski(Director)Frank Flaut III(Director)Christopher Gabrieli(Director)
Board seatStephen ReedersAkhilesh Pathipati· per SEC Form D
Co-investorsBessemer Venture Partners
Leader in non-invasive cardiac output and hemodynamic monitoring with its CHEETAH NICOM system; based in Newton, MA with offices in Tel-Aviv and Portland.
HealthtechNewton, US
Christopher Hutchison(Executive Officer, Director)inKevin McArdle(Executive Officer)Yuval Rozen(Executive Officer)
BoardSteven Reeders(Director)Renard Charity(Director)inAnthony Moshal(Director)
Board seatStephen Reeders· per SEC Form D
Co-investorsAscension VenturesBosch VenturesHighCape Capital
CurvaFix develops the CurvaFix Low Profile intramedullary nailing system, curved implants for surgical stabilization of pelvic fractures.
HardwareHealthtechMedical DevicesBellevue, US
Jeffrey Poole(Executive Officer)Mark Foster(Executive Officer, Director)inSteven Dimmer(Executive Officer, Director, Promoter)Dong-Gun Kim(Director)
Board seatJack TanakaEric Fritz· per SEC Form D
Co-investorsAlliance of AngelsArieal Southeast Angel PartnersRockies Venture ClubSPRINGROCK VENTURESSwan Venture FundKeiretsu Capital+2 more
FemTechHealthtechMedical DevicesRedwood City, US
Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)
BoardKen Haas(Director)Jonathan MacQuitty(Director)inMike Carusi(Director)inDoug Fisher(Director)
Board seatHugo Harrod· per SEC Form D · $92.2M raise · filed Nov 2023
Co-investorsAmzak HealthBain Capital Life SciencesEndeavour VisionFemHealth VenturesKaiser Permanente VenturesKluz Ventures+6 more
Nalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain.
HardwareHealthtechMedical DevicesCarlsbad, US
Earl Fender(President & CEO)inLee Hartley(Executive Officer)inAllen Meacham(Executive Officer)inBick Sellers(Executive Officer)inThomas A. West(Executive Officer, Director)inJeffrey Swiecki(Executive Officer)
Board seatHugo Harrod· per SEC Form D
Co-investorsAdvent Life SciencesAPERTURE Venture PartnersB Capital GroupB4 CapitalDecheng CapitalEndeavour Vision+4 more
.jpeg){kind=logo}
Optinose is a specialty pharmaceutical company that develops and markets products for patients with conditions treated by ear, nose, and throat (ENT) and allergy specialists.
BiotechHealthtechMedical DevicesYardley, US
Per Djupesland(Executive Officer, Director)inMichele Janis(Executive Officer)Peter Miller(Executive Officer, Director)inTerrence Terifay(Executive Officer)Ramy Mahmoud(Executive Officer)in
BoardKlaas De Boer(Director)
Board seatEric BednarskiKyle Dempsey· per SEC Form D
Co-investorsAvistaForesite Capital
Tarsa Therapeutics developed TBRIA, an oral formulation of calcitonin for treating postmenopausal osteoporosis in women more than five years post menopause when other treatments are unsuitable.
BiotechPhiladelphia, US
David Brand(Executive Officer, Director)inGregory Lumpkin(Executive Officer)
BoardRichard Kollender(Director)Martin Edwards(Director)Derek Ferguson(Director)
Board seatEric Bednarski· per SEC Form D
Co-investorsForesite CapitalOxford Finance LLCQuaker BioVentures
Vertos Medical (part of Stryker's Interventional Spine business) develops minimally invasive interventional treatments for chronic pain and reduced mobility, including vertebral augmentation, bone tumor ablation, and basivertebral nerve ablation.
HealthtechMedical DevicesAliso Viejo, US
Eric Wichems(Executive Officer, Director)inRebecca Colbert(Executive Officer)in
BoardMyles Greenberg(Director)Daniel Pelak(Director)Ittai Harel(Director)inJohn Ryan(Director)
Board seatHugo Harrod· per SEC Form D
Co-investorsNorwest Venture PartnersPitango
HealthtechCampbell, US
Nersi Nazari(Executive Officer, Director)inSteve Zadig(Executive Officer, Director)in
BoardRichard Feachem(Director)Tom Saunders(Director)
Board seatStephen Reeders· per SEC Form D · $38.1M raise · filed Oct 2017
Co-investorsAsahi Kasei Corporate Venture CapitalEssex Woodlands Healthcare PartnersRevelation PartnersAlly Bridge GroupTrinity Capital
Innovator in non-invasive surgical skin closure devices used in over 100,000 cases across 30+ countries; headquartered in Campbell, CA.
Campbell, US
Amir Belson(Director)John Tighe(Executive Officer, Director)in
BoardPatrick Berbon(Director)Balaji Muralidhar(Director)
Board seatStephen Reeders· per SEC Form D · $26.9M raise · filed Jan 2016
Co-investorsClaremont Creek VenturesHighCape CapitalXSeed Capital
AmbioPharm is a contract manufacturer of custom peptide active pharmaceutical ingredients (APIs), providing process development, scale-up, and cGMP manufacturing for late-stage clinical and commercial peptide products.
Advanced ManufacturingBiotechHealthtechNorth Augusta, US
Avanzanite is a biopharmaceutical commercialization and distribution company that partners with emerging research-based drug originators to license and distribute approved orphan (rare disease) medicines across European markets.
BiotechHealthtechAmsterdam, NL
Adam Plich(Founder, CEO & Executive Board Member)inAnant Murthy(Founder & Board Member)Abdel Omari(Chief Financial Officer & Executive Board Member)in
Biotheranostics develops proprietary genomic assays used to support personalized disease management in oncology.
BiotechHealthtechMedical DevicesSan Diego, US
Nicholas Barthelemy(Executive Officer, Director, Promoter)
BoardDavid Kabakoff(Director)inEric Bednarski(Director)Alejandro Sanchez(Director)in
Co-investorsEvidity Health CapitalHealthQuest Capital
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells.
BiotechHealthtechMedical Devices
David G. Brachman, MD, FASTRO(Co-Founder and Chief Technology Officer)Heyoung McBride, MD, MS, FASTRO(Co-Founder)Peter Nakaji, MD(Co-Founder)inEmad Youssef, MD(Co-Founder)Theresa Thomas, MS, CCRC(Co-Founder)Per Langoe(Chief Executive Officer)in
Co-investorsAccelmed PartnersBlueStone Venture PartnersEvidity Health CapitalFemHealth VenturesGilde HealthcareMedTech Venture Partners+1 more
Momenta develops autonomous driving technology focused on improving road safety by reducing traffic accidents caused by speeding and collision risks.
AI & Machine LearningHardwareMobility & TransportationRoboticsBeijing, CN
Cao Xudong(Founder)
Co-investorsJoy CapitalWelight CapitalZhenFund
Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.
HardwareHealthtechMedical Devices
Co-investorsAtlantic Bridge VenturesClaret Capital PartnersFountain Healthcare PartnersSofinnova PartnersEnterprise IrelandEQT Life Sciences+1 more
OSSIO develops OSSIOfiber, a bio-integrative bone fixation implant material made from natural mineral fibers that provides stability during healing and integrates fully into bone over 18-24 months, avoiding permanent metal hardware.
BiotechHealthtechMedical DevicesNew MaterialsPalmetto, US
Orahn Preiss-Bloom(Founder & Chief Innovation Officer)inBrian Verrier(Chief Executive Officer)inBrennan Marilla(Chief Commercial and Operating Officer)inMoshe Shneor(Chief Financial Officer)inGregory C. Berlet(Chief Medical Officer)
Co-investorsOCV PartnersQuesta CapitalSecocha Ventures
ProVerum is a venture-backed medical device startup developing minimally invasive technologies to treat benign prostatic hyperplasia (BPH).
HardwareHealthtechMedical DevicesDublin, IE
Dr Conor Harkin(Founder)inRíona Ní Ghriallais(Founder)in
Co-investorsAtlantic Bridge VenturesIreland Strategic Investment FundLightstone VenturesOrbiMed
HealthtechIrvine, US
Kenny Chang(Executive Officer)W. Ronald Redmond(Director)Vijay Dhaka(Executive Officer)Philong Pham(Executive Officer, Director)Hongsheng Tong(Executive Officer, Director)
Co-investorsBlackRockEndeavour VisionRTW Investments L.P.Soleus CapitalvenBio Global StrategicVivo Capital
Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.
HealthtechMedical DevicesPlymouth, US
Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)
Co-investorsHM Venture PartnersEnterprise IrelandGilde HealthcareIreland Strategic Investment FundLegend CapitalLightstone Ventures+1 more
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings.
BiotechHealthtechMedical Devices
Co-investorsBrace PharmaRunway Growth Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
eyeBrain MedicalAegerionBioProtectCara TherapeuticsGT Medical TechnologiesPregLem
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.